IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.317
NA - Nord America 10.211
AS - Asia 5.285
SA - Sud America 1.844
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 143
OC - Oceania 21
Totale 28.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.013
RU - Federazione Russa 5.114
SG - Singapore 2.407
BR - Brasile 1.578
CN - Cina 1.401
SE - Svezia 1.197
IE - Irlanda 1.169
HK - Hong Kong 627
FR - Francia 561
DE - Germania 539
IT - Italia 485
UA - Ucraina 381
GB - Regno Unito 307
VN - Vietnam 271
FI - Finlandia 230
PL - Polonia 116
IN - India 100
BD - Bangladesh 97
AR - Argentina 89
CA - Canada 72
MX - Messico 60
NL - Olanda 46
TR - Turchia 46
ZA - Sudafrica 44
EC - Ecuador 43
AT - Austria 40
CO - Colombia 38
IQ - Iraq 38
JP - Giappone 38
ID - Indonesia 32
MA - Marocco 29
ES - Italia 27
UZ - Uzbekistan 27
BE - Belgio 26
VE - Venezuela 24
PY - Paraguay 21
CL - Cile 20
PK - Pakistan 19
AZ - Azerbaigian 18
KZ - Kazakistan 16
AU - Australia 15
NP - Nepal 15
KE - Kenya 14
MY - Malesia 14
PE - Perù 14
JM - Giamaica 13
JO - Giordania 13
SA - Arabia Saudita 13
PH - Filippine 12
NI - Nicaragua 11
TN - Tunisia 11
AL - Albania 10
CR - Costa Rica 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
DO - Repubblica Dominicana 7
EG - Egitto 7
GE - Georgia 7
GT - Guatemala 7
LT - Lituania 7
SN - Senegal 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
BO - Bolivia 5
GA - Gabon 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
RO - Romania 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AO - Angola 4
BY - Bielorussia 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
KW - Kuwait 3
AM - Armenia 2
BW - Botswana 2
CI - Costa d'Avorio 2
GY - Guiana 2
Totale 27.798
Salva come PNG Salva come JPEG
Città #
Moscow 1.579
Singapore 1.335
Dublin 1.165
Ashburn 1.123
Chandler 934
Dallas 806
Jacksonville 763
Hong Kong 626
Nyköping 502
San Jose 486
Beijing 453
Council Bluffs 311
Princeton 218
The Dalles 214
Lauterbourg 202
Los Angeles 194
Dearborn 191
Cambridge 183
Des Moines 173
Messina 145
Medford 141
São Paulo 129
Buffalo 124
Boardman 112
Lancaster 112
Munich 105
Ho Chi Minh City 98
Ann Arbor 93
Warsaw 93
Santa Clara 73
Woodbridge 69
Atlanta 60
Frankfurt am Main 60
Redondo Beach 60
Tianjin 59
Jinan 58
Rio de Janeiro 57
Hanoi 54
New York 53
Wilmington 53
Bremen 48
Guangzhou 48
Shenyang 48
Belo Horizonte 43
Orem 43
San Mateo 41
Seattle 40
Nuremberg 36
Turku 35
Tokyo 34
Columbus 32
Brooklyn 31
Houston 29
Chennai 28
Zhengzhou 28
Curitiba 26
Hebei 26
London 26
Brasília 25
Brussels 25
Shenzhen 25
Chicago 24
Vienna 24
Catania 23
Nanjing 23
Ningbo 23
San Francisco 23
Campinas 22
Denver 22
Tashkent 22
Phoenix 21
Shanghai 21
Amsterdam 20
Stockholm 19
Dhaka 18
Haikou 18
Helsinki 18
Rome 18
Boston 17
Changsha 17
Hangzhou 17
Johannesburg 17
Porto Alegre 17
Washington 17
Baghdad 16
Baku 16
Hyderabad 16
Düsseldorf 15
Manchester 15
Mexico City 15
Milan 15
Bogotá 14
Jiaxing 14
Memphis 14
Quito 14
Taizhou 14
Poplar 13
Fortaleza 12
Guayaquil 12
Montreal 12
Totale 14.671
Salva come PNG Salva come JPEG
Nome #
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 293
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 282
Bone density and calcium metabolism in patients with long standing, quiescent Crohn's disease 224
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 224
Bone metabolism in orthotopic liver transplantation: a prospective study 220
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 220
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 217
Microradiographic anatomy of the explanted rat colon 216
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 215
Effect of experimental colitis on bone metabolism in the rat 213
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 202
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat 196
Changing approach to gastroenteropancreatic tumours. Case report of a gastrinoma metastasis localised by somatostatin-receptor scintigraphy 196
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 194
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 192
Impairment of bone and mineral metabolism after pancreas transplantation – Observations in the syngeneic rat. 190
Effects of jejuno-ileal bypass on oxalate and mineral metabolism. 188
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 185
Orchiectomy-induced osteoporosis in the rat – A preliminary report on the state of mineral and bone metabolism, and its response to oral calcium-sodium-citrate. 183
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 181
Disturbances of mineral and bone metabolism following gastric antrectomy in the rat. 180
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 180
Alexithymia and inflammatory bowel disease: A systematic review 178
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 178
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 174
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 173
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 169
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 169
OCT Performance in the Diagnosis of Ulcerative Colitis 168
Quality of life in inflammatory bowel disease. 166
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 163
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 161
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 159
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 159
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 159
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 159
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 158
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 156
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 156
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 155
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 155
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 154
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 154
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 153
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 153
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 150
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 150
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 150
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 150
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 148
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 147
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 146
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 145
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 145
The aged gut in inflammatory bowel diseases. 145
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 144
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 143
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 143
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 143
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 143
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 143
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 142
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 141
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 141
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 141
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 140
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 140
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 138
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 138
Clinical practice in the management of ulcerative colitis - an Italian survey 136
Mucosal Immunology and Probiotics. 136
Vitamin D and inflammatory bowel disease 135
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 134
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy 134
IBD-associated bone loss: is inflammation the explanation? 133
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 133
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 133
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 133
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 133
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 132
Metacognition and negative emotions in clinical practice. A preliminary study with patients with bowel disorder 132
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 131
Hongos productores de biopelículas como causa emergente de infecciones por vía hemática en la enfermedad inflamatoria intestinal 131
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 130
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 130
Acute onset of Lupus associated Pancreatitis Mimicking Pancreatic Cancer 130
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 128
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 128
Experimental colitis increases small intestine permeability in the rat 127
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 127
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions. 127
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study 127
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 126
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 125
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 124
Comment to "Management of cytomegalovirus infection in inflammatory bowel diseases" 124
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 122
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 122
Treatment of life threatening type I refractory celiac disease with long term infliximab 122
Predicting response to thiopurines – a single centre experience. 122
Totale 15.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.398 0 190 30 40 45 15 62 46 15 333 194 428
2022/20233.388 301 272 153 299 284 319 39 177 1.404 17 89 34
2023/2024790 69 116 87 130 89 102 21 30 2 69 8 67
2024/20254.374 64 56 129 231 255 196 147 885 1.110 224 338 739
2025/202611.999 464 764 864 751 973 2.700 1.527 1.572 1.481 496 196 211
2026/20272.328 337 1.991 0 0 0 0 0 0 0 0 0 0
Totale 28.273